Unknown

Dataset Information

0

A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation.

ABSTRACT:

SUBMITTER: Modi D 

PROVIDER: S-EPMC6743316 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation.

Modi Dipenkumar D   Al-Kadhimi Zaid Z   Chen Wei W   Jang Hyejeong H   Deol Abhinav A   Ayash Lois L   Bhutani Divaya D   Alavi Asif A   Ratanatharathorn Voravit V   Uberti Joseph P JP  

American journal of hematology 20180205 4

Similar Datasets

Unknown PTCy-based graft-versus-host disease prophylaxis for matched sibling donor allogeneic hematopoietic cell transplantation.
| S-EPMC11881745 | biostudies-literature
Unknown Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxis.
| S-EPMC3589900 | biostudies-literature
Unknown Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation.
| S-EPMC7571859 | biostudies-literature
Unknown Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation.
| S-EPMC11530361 | biostudies-literature
Unknown A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation.
| S-EPMC5394879 | biostudies-literature
Unknown Impact of Donor Statin Treatment on Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
| S-EPMC10695696 | biostudies-literature
Unknown Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation.
| S-EPMC3625710 | biostudies-literature
Unknown Letermovir for Prevention of Cytomegalovirus Reactivation in Haploidentical and Mismatched Adult Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
| S-EPMC8441845 | biostudies-literature
Unknown Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT).
| S-EPMC4706501 | biostudies-literature
Unknown Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease.
| S-EPMC9980553 | biostudies-literature